Trial intelligence / Profile preview

Topical ciprofloxacin and betamethasone after tympanoplasty or tympanomastoidectomy

IRCT20200728048241N1Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Mar 2013
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of ciprofloxacin and betamethasone in chronic otitis media (COM) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Otorrhea, Graft success and 2 more. Started Mar 2013; status: completed.

02

Drugs

ciprofloxacinbetamethasone
03

Conditions

chronic otitis media (COM)

Beyond the preview

Go deeper on IRCT20200728048241N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200728048241N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call